Basic science and translational implications of current knowledge on neuroendocrine tumors

Lynnette Fernandez-Cuesta1, Nicolas Alcala1, Emilie Mathian1

  • 1Computational Cancer Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Summary

Neuroendocrine tumors (NETs) are increasingly diagnosed, necessitating updated classifications. Understanding NET biology, tumor microenvironment, and cells of origin is crucial for personalized therapies.